Artur Machlenkin
Direttore Tecnico/Scientifico/R&S presso PLURI INC.
Profilo
Artur Machlenkin is currently the Chief Scientific Officer at Pluri, Inc. He previously worked as the Chief Executive Officer at Pantheon Biosciences Ltd.
and as the Head-Immuno Oncology at Compugen Usa, Inc. Dr. Machlenkin holds a doctorate degree from the Weizmann Institute of Science.
Posizioni attive di Artur Machlenkin
| Società | Posizione | Inizio |
|---|---|---|
| PLURI INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2022 |
Precedenti posizioni note di Artur Machlenkin
| Società | Posizione | Fine |
|---|---|---|
| Compugen Usa, Inc. | Corporate Officer/Principal | - |
Pantheon Biosciences Ltd.
 Pantheon Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Pantheon Biosciences Ltd. is an Israeli company that develops molecular therapies and tools. The company is based in Yavne, Israel and was founded in 2017. | Amministratore Delegato | - |
Formazione di Artur Machlenkin
| Weizmann Institute of Science | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PLURI INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Pantheon Biosciences Ltd.
Pantheon Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Pantheon Biosciences Ltd. is an Israeli company that develops molecular therapies and tools. The company is based in Yavne, Israel and was founded in 2017. | Commercial Services |
| Compugen Usa, Inc. |
- Borsa valori
- Insiders
- Artur Machlenkin